Integer is a medical devices business based in the US. Integer shares (ITGR) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $121.00 – a decrease of 1.6% over the previous week. Integer employs 11,000 staff and has a trailing 12-month revenue of around $1.7 billion.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $121.00 |
|---|---|
| 52-week range | $104.93 - $146.36 |
| 50-day moving average | $120.61 |
| 200-day moving average | $127.82 |
| Wall St. target price | $148.75 |
| PE ratio | 56.2791 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $2.15 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $121 from 2025-07-03
| 1 week (2025-06-27) | -1.27% |
|---|---|
| 1 month (2025-06-06) | -0.27% |
| 3 months (2025-04-07) | 7.15% |
| 6 months (2025-01-07) | -8.44% |
| 1 year (2024-07-05) | 4.01% |
|---|---|
| 2 years (2023-07-06) | 42.69% |
| 3 years (2022-07-06) | 74.86% |
| 5 years (2020-07-07) | 75.24% |
Valuing Integer stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Integer's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Integer's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 56x. In other words, Integer shares trade at around 56x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Integer's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.942. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Integer's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Integer's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $344.9 million.
The EBITDA is a measure of a Integer's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $1.7 billion |
|---|---|
| Operating margin TTM | 12.67% |
| Gross profit TTM | $473.3 million |
| Return on assets TTM | 4.51% |
| Return on equity TTM | 4.98% |
| Profit margin | 4.4% |
| Book value | $46.05 |
| Market Capitalization | $4.2 billion |
TTM: trailing 12 months
We're not expecting Integer to pay a dividend over the next 12 months.
Over the last 12 months, Integer's shares have ranged in value from as little as $104.93 up to $146.36. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Integer's is 0.983. This would suggest that Integer's shares are less volatile than average (for this exchange).
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Puerto Rico, Costa Rica, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was formerly known as Greatbatch, Inc.
These are the stocks to buy when you don’t have much to spend.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Interactive Brokers is the best overall international brokerage account on our list, followed by Moomoo, Fidelity, Charles Schwab and TradeStation.
These are the best discount brokers of 2025 according to Finder’s comprehensive review.
Discover the best stock picking services based on expert analysis, pricing, and strategy fit. Compare top tools to find the right service for your investing style in 2025.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
We’ve rounded up stats on some of the most popular oil stocks, along with information on how they compare and how to invest.
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .